.BETA.-D-GLUCOPYRANOSIDURONIC ACID, 2-(8-(2-((1,2-DIHYDRO-2-OXO-4-QUINOLINYL)OXY)ETHYL)-5,6-DIHYDRO-5-METHYL-6-OXO-11H-DIPYRIDO(3,2-B:2',3'-E)(1,4)DIAZEPIN-11-YL)ETHYL
UNII PG76HAS2AD
Substance Identification & Data
This profile provides standardized clinical and technical data for .beta.-d-glucopyranosiduronic Acid, 2-(8-(2-((1,2-dihydro-2-oxo-4-quinolinyl)oxy)ethyl)-5,6-dihydro-5-methyl-6-oxo-11h-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-11-yl)ethyl, uniquely identified by the FDA Unique Ingredient Identifier (UNII) PG76HAS2AD.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1426843-25-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C31H31N5O10 NFJILBMQGKMUCW-UDMYXELHSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for .beta.-d-glucopyranosiduronic Acid, 2-(8-(2-((1,2-dihydro-2-oxo-4-quinolinyl)oxy)ethyl)-5,6-dihydro-5-methyl-6-oxo-11h-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-11-yl)ethyl. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.